Significantly, the JNK inhibitor SP600125 or the antioxidant NAC both alleviated SKI-349-induced pNSCLC-1 cell death (Fig. 4G) and apoptosis (Fig. 4H) in NSCLC cells. Here, MAPK8 is linked to non-small cell lung carcinoma.